| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |